Mark Tegen

Mr. Tegen has over 25 years of petroleum, green energy and green chemical industry experience. In 2018, he co-founded Socati Corp (publicly listed TSX:LVVEF), a cannabinoid biotechnology company producing targeted hemp seed genetics; contract row crop production in Colorado and Montana; and cannabinoid extraction and purification through continuous gradient elution and simulated moving bed chromatography. He currently serves as Executive Director Engineering for Cleen Technology, which has transformed the continuous chromatography technology developed at Socati into an equipment and technology licensing platform for application in the worldwide medical and recreational cannabis markets. Mr. Tegen co-founded Inventure in 2007, and served as the company’s Chief Executive Officer until 2018. During his tenure, the company developed several patented process technologies, including Mixed Super Critical Fluid and Soap Carbonate Technology.

Before launching Inventure, he was CEO of Senergy Chemical, which he formed after licensing a novel patent to convert glycerin into propylene glycol. The technology won the 2006 Presidential Green Chemistry Award. Prior to forming Senergy, Mr. Tegen was President of Pacific Fluids LLC, the largest specialty chemical manufacturer, terminal in the Pacific Northwest. During his term with Senergy Chemical and Pacific Fluids. Mr. Tegen oversaw the marketing, sales, product development, and manufacturing of petrochemical products for customers including Octagon Process, Boeing, Castrol, British Petroleum, Kaiser Aluminum, and others. In addition, he has also developed or co-developed 17 patents and patent applications. He received his degree in Business from the University of Washington.